The First Affiliated Hospital of Zhengzhou University
3 clinical trials · 3 recruiting · OTHER
Trials by The First Affiliated Hospital of Zhengzhou University
RECRUITINGPhase 2NCT07294664
PD1/TGFβ In Combination With EZH2 And Chemotherapy For First - Line Treatment Of Gastric Cancer
Immunotherapy combined with chemotherapy has become the standard first-line treatment regimen for gastric cancer. However, a subset of patients still fail to benefit or derive...
Sponsor: The First Affiliated Hospital of Zhengzhou UniversityEnrolling: 361 location
Advanced Gastric CancerSHR1701
RECRUITINGPhase 2NCT07016724
Neoadjuvant Radiochemotherapy Combined With Cadonilizumab for Local Advanced Esophageal Squamous Cell Cancer
Esophageal squamous cell cancer (ESCC) has a high incidence in China. Although the fast development of immune check point inhibitors (ICIs), the rate of pCR is limited with the...
Sponsor: The First Affiliated Hospital of Zhengzhou UniversityEnrolling: 2081 location
Esophageal Squamous Cell Carcinoma
RECRUITINGNCT07169656
Observation Study on Reducing the Risk of Liver Cancer Associated With Hepatitis B (Zhiyuan) Project.
This study is a multicenter, prospective, observational real-world study designed to investigate and analyze the current treatment patterns of chronic hepatitis B (CHB) across 200...
Sponsor: The First Affiliated Hospital of Zhengzhou UniversityEnrolling: 1500020 locations
Chronic Hepatitis b